{"hands_on_practices": [{"introduction": "To master retinal electrophysiology, we must begin at the source: the flow of ions through channels in the photoreceptor membrane. This foundational practice bridges the gap between the microscopic world of single-channel biophysics and the macroscopic currents that initiate the entire process of vision. By applying Ohm's law and principles of statistical expectation to a population of ion channels, you will calculate the photoreceptor \"dark current,\" a cornerstone concept in understanding phototransduction [@problem_id:4721681].", "problem": "A vertebrate rod photoreceptor in darkness carries the so-called dark current through cyclic guanosine monophosphate (cGMP)-gated channels, which are approximately ohmic over the physiological range of membrane potentials. Consider a patch of membrane containing $N=200$ identical cGMP-gated channels. Each channel has a single-channel conductance $20\\,\\mathrm{pS}$, and at steady-state in darkness the open probability is $P_{\\mathrm{open}}=0.2$. The membrane potential relative to the channel’s reversal potential defines the driving force, whose magnitude is $40\\,\\mathrm{mV}$. Assume channels are independent, the single-channel current obeys Ohm’s law, and the total current is the sum of currents through open channels.\n\nStarting from first principles appropriate for retinal electrophysiology—specifically, the definition of driving force, Ohm’s law at the single-channel level, and statistical expectation for independent identical channels—derive the expression for the mean dark current carried by these channels and compute its numerical value for the given parameters. Express your final answer in picoamperes and round your answer to three significant figures.", "solution": "The dark current in a rod photoreceptor arises from ions passing through cyclic guanosine monophosphate (cGMP)-gated channels. For an ohmic channel, the single-channel current $i$ is given by Ohm’s law applied at the channel level,\n$$\ni = g_{\\mathrm{single}} \\, V_{\\mathrm{drive}},\n$$\nwhere $g_{\\mathrm{single}}$ is the single-channel conductance and $V_{\\mathrm{drive}}$ is the driving force, defined as the membrane potential relative to the channel’s reversal potential. The total current $I$ across $N$ independent identical channels is the sum of the currents through all open channels. Let $X$ be the random number of open channels. Under independence with open probability $P_{\\mathrm{open}}$, $X$ is a binomial random variable with expectation\n$$\n\\mathbb{E}[X] = N \\, P_{\\mathrm{open}}.\n$$\nBecause each open channel contributes the same deterministic single-channel current $i$, the mean total current is\n$$\n\\mathbb{E}[I] = \\mathbb{E}[X] \\cdot i = N \\, P_{\\mathrm{open}} \\, g_{\\mathrm{single}} \\, V_{\\mathrm{drive}}.\n$$\nWe now substitute the given values, converting to base units. The single-channel conductance is $g_{\\mathrm{single}} = 20\\,\\mathrm{pS} = 20 \\times 10^{-12}\\,\\mathrm{S}$. The driving force magnitude is $V_{\\mathrm{drive}} = 40\\,\\mathrm{mV} = 40 \\times 10^{-3}\\,\\mathrm{V}$. The number of channels is $N = 200$, and the open probability is $P_{\\mathrm{open}} = 0.2$. Therefore,\n$$\n\\mathbb{E}[I] = (200) \\times (0.2) \\times (20 \\times 10^{-12}\\,\\mathrm{S}) \\times (40 \\times 10^{-3}\\,\\mathrm{V}).\n$$\nCompute stepwise:\n$$\n200 \\times 0.2 = 40,\n$$\nand\n$$\n(20 \\times 10^{-12}) \\times (40 \\times 10^{-3}) = (800) \\times 10^{-15} = 8.00 \\times 10^{-13}.\n$$\nThus,\n$$\n\\mathbb{E}[I] = 40 \\times \\left(8.00 \\times 10^{-13}\\,\\mathrm{A}\\right) = 3.20 \\times 10^{-11}\\,\\mathrm{A}.\n$$\nConvert amperes to picoamperes using $1\\,\\mathrm{pA} = 10^{-12}\\,\\mathrm{A}$:\n$$\n3.20 \\times 10^{-11}\\,\\mathrm{A} = 32.0\\,\\mathrm{pA}.\n$$\nRounding to three significant figures yields $32.0\\,\\mathrm{pA}$.", "answer": "$$\\boxed{32.0}$$", "id": "4721681"}, {"introduction": "The electroretinogram (ERG) is a composite signal, summing the electrical responses of various retinal cell layers. A key skill is the ability to dissect this complex waveform to pinpoint the health and function of specific pathways. This exercise simulates a classic pharmacological experiment, challenging you to predict and quantify how a specific drug, L-AP4, alters the ERG by selectively silencing the ON-pathway, thereby unmasking the distinct contributions of photoreceptors and bipolar cells to the final recording [@problem_id:4721698].", "problem": "A dark-adapted scotopic Electroretinogram (ERG) is measured in an ex vivo primate retina preparation under a single-flash stimulus of intensity $I = 0.01 \\ \\mathrm{cd} \\cdot \\mathrm{s} \\cdot \\mathrm{m}^{-2}$ following $30$ minutes of dark adaptation. Baseline waveforms are recorded, then the bath is perfused with L-2-amino-4-phosphonobutyric acid (L-AP4), a selective agonist of the metabotropic glutamate receptor 6 (mGluR6) located on rod-driven ON bipolar cells. After $10$ minutes of equilibration, the same stimulus is repeated.\n\nFoundational definitions and facts for retinal electrophysiology:\n- The ERG $a$-wave primarily reflects the outer retinal photoreceptor hyperpolarization (classically termed slow PIII of the ERG), driven by reduced cyclic guanosine monophosphate (cGMP)-gated current in rods under light.\n- The ERG $b$-wave primarily reflects the inner retinal ON bipolar cell depolarization (often referred to as PII), which normally arises because light reduces glutamate release from rods, decreasing activation of metabotropic glutamate receptor 6 (mGluR6), thereby opening Transient Receptor Potential Melastatin 1 (TRPM1) channels and depolarizing ON bipolar cells.\n- Oscillatory potentials (OPs) are high-frequency components superimposed on the rising limb of the $b$-wave and are attributed to inner retinal circuits, predominantly amacrine cell activity.\n- The recorded ERG can be viewed phenomenologically as the sum $V(t) = PIII(t) + PII(t) + OP(t) + \\text{other minor components}$, where $PIII(t)$ is dominated by photoreceptors, $PII(t)$ by ON bipolar cells, and $OP(t)$ by amacrine-driven oscillations.\n\nMechanistic context:\n- In darkness, rods release glutamate that activates mGluR6 on ON bipolar dendrites, closing TRPM1 cation channels and maintaining ON bipolar cells in a relatively hyperpolarized state.\n- Under light, rod glutamate release decreases; mGluR6 activation falls; TRPM1 channels open; ON bipolar cells depolarize, generating the $b$-wave.\n- L-AP4, by agonizing mGluR6, mimics the effect of glutamate in darkness and prevents the light-evoked depolarization of ON bipolar cells, selectively suppressing the ON pathway component of the ERG under scotopic conditions.\n\nMeasured amplitudes (peak-to-baseline for the $b$-wave; trough-to-baseline for the $a$-wave; OP envelope peak-to-peak) are as follows:\n- Baseline $a$-wave amplitude: $A_{0} = 200 \\ \\mu \\mathrm{V}$.\n- Baseline $b$-wave amplitude: $B_{0} = 420 \\ \\mu \\mathrm{V}$.\n- Baseline OP envelope amplitude: $O_{0} = 60 \\ \\mu \\mathrm{V}$.\n- Post–L-AP4 $a$-wave amplitude: $A_{1} = 190 \\ \\mu \\mathrm{V}$.\n- Post–L-AP4 residual $b$-wave amplitude: $B_{1} = 50 \\ \\mu \\mathrm{V}$.\n- Post–L-AP4 OP envelope amplitude: $O_{1} = 15 \\ \\mu \\mathrm{V}$.\n\nUsing only the principles and facts above (without introducing shortcut formulas beyond standard definitions of amplitude changes), reason from the cellular mechanisms to predict the qualitative waveform alterations under L-AP4 and compute the percent suppression of the $b$-wave attributable to ON pathway blockade. Choose the option that best matches both the mechanistic expectation and the quantitative result.\n\nA. L-AP4 produces an electronegative ERG by abolishing ON bipolar depolarization: the $a$-wave is largely preserved with a small decrement, the $b$-wave is strongly suppressed, and OPs are attenuated; the percent $b$-wave suppression computed from the given amplitudes is approximately $88\\%$.\n\nB. L-AP4 primarily reduces photoreceptor hyperpolarization, halving the $a$-wave; the $b$-wave latency shortens and amplitude suppression is less than $10\\%$; OPs increase due to disinhibition.\n\nC. L-AP4 selectively enhances OFF pathway signals, converting the scotopic $b$-wave into a large positive “$d$-wave” with a net $b$-wave amplitude increase of about $30\\%$; OPs remain unchanged.\n\nD. L-AP4 blocks glutamate release from rods and thus equally suppresses $a$- and $b$-waves by about $75\\%$; OPs are unaffected because they are generated distal to bipolar cells.", "solution": "The problem statement is evaluated to be valid. It is scientifically grounded in established principles of retinal electrophysiology, well-posed with sufficient and consistent data, and objectively phrased. The provided data are realistic for the described experiment. The task requires a qualitative prediction based on given mechanisms and a quantitative calculation, both of which are feasible.\n\nThe solution proceeds in two parts: first, a qualitative analysis of the consequences of the pharmacological intervention based on the provided cellular mechanisms, and second, a quantitative calculation of the change in $b$-wave amplitude.\n\n**1. Qualitative Analysis from First Principles**\n\nThe problem describes a scotopic Electroretinogram (ERG), which is dominated by the activity of the rod pathway. The key mechanistic points are:\n1.  In darkness, rod photoreceptors are depolarized and continuously release the neurotransmitter glutamate.\n2.  This glutamate acts on metabotropic glutamate receptors (mGluR6) on the dendrites of rod ON bipolar cells.\n3.  Activation of mGluR6 by glutamate initiates an intracellular signaling cascade that closes cation channels (TRPM1), keeping the ON bipolar cell in a relatively hyperpolarized state.\n4.  A flash of light hyperpolarizes the rod photoreceptors, reducing their glutamate release.\n5.  The reduction in glutamate concentration leads to decreased activation of mGluR6 receptors. This, in turn, allows the TRPM1 channels to open, leading to an influx of positive ions and depolarization of the ON bipolar cell.\n6.  This ON bipolar cell depolarization is the primary generator of the positive-going $b$-wave of the scotopic ERG, also known as the $\\mathrm{PII}$ component.\n\nThe pharmacological agent, L-2-amino-4-phosphonobutyric acid (L-AP4), is a selective agonist of mGluR6. As an agonist, L-AP4 mimics the action of glutamate at these receptors. By perfusing the retina with L-AP4, the mGluR6 receptors on ON bipolar cells become tonically activated, irrespective of the amount of glutamate being released by the photoreceptors. This \"locks\" the ON bipolar cell in its dark-adapted, hyperpolarized state by keeping the TRPM1 channels closed.\n\nConsequently, when a light flash is presented in the presence of L-AP4, the photoreceptors will still hyperpolarize and reduce their glutamate release as normal. However, this change in glutamate levels is inconsequential for the ON bipolar cells, as their mGluR6 receptors are already saturated by L-AP4. The ON bipolar cells will fail to depolarize.\n\nBased on this mechanism, we can predict the following changes to the ERG waveform:\n-   **$a$-wave**: The $a$-wave ($\\mathrm{PIII}$) originates from the hyperpolarization of photoreceptors. Since L-AP4 acts postsynaptically on bipolar cells, the photoreceptor response should be largely unaffected. We expect the $a$-wave amplitude to be preserved or only minimally changed. The data shows a small reduction from $A_{0} = 200 \\ \\mu\\mathrm{V}$ to $A_{1} = 190 \\ \\mu\\mathrm{V}$, which is consistent with \"largely preserved\".\n-   **$b$-wave**: The $b$-wave ($\\mathrm{PII}$) originates from ON bipolar cell depolarization. As this process is blocked by L-AP4, a massive reduction or complete abolition of the $b$-wave is expected. The ERG waveform is a summation of components. Removing the large, positive $\\mathrm{PII}$ component will unmask the underlying negative $\\mathrm{PIII}$ component. This results in what is called an \"electronegative\" ERG, where the major peak is negative (the $a$-wave) and the subsequent positive deflection is severely diminished. The data confirms this, with the $b$-wave amplitude plummeting from $B_{0} = 420 \\ \\mu\\mathrm{V}$ to $B_{1} = 50 \\ \\mu\\mathrm{V}$.\n-   **Oscillatory Potentials (OPs)**: OPs arise from activity in inner retinal circuits, largely involving amacrine cells, which receive significant input from bipolar cells. By blocking the ON bipolar cell response, a major driving input to these circuits is removed. Therefore, the OPs are expected to be significantly attenuated. The data confirms this, showing a drop from $O_{0} = 60 \\ \\mu\\mathrm{V}$ to $O_{1} = 15 \\ \\mu\\mathrm{V}$.\n\n**2. Quantitative Calculation of $b$-wave Suppression**\n\nThe problem asks for the percent suppression of the $b$-wave. This is calculated as the fractional decrease in amplitude relative to the baseline.\n\nThe initial (baseline) $b$-wave amplitude is $B_{0} = 420 \\ \\mu\\mathrm{V}$.\nThe final (post-L-AP4) $b$-wave amplitude is $B_{1} = 50 \\ \\mu\\mathrm{V}$.\n\nThe change in amplitude is $\\Delta B = B_{0} - B_{1} = 420 \\ \\mu\\mathrm{V} - 50 \\ \\mu\\mathrm{V} = 370 \\ \\mu\\mathrm{V}$.\n\nThe percent suppression is calculated as:\n$$\n\\text{Percent Suppression} = \\frac{\\Delta B}{B_{0}} \\times 100\\% = \\frac{B_0 - B_1}{B_0} \\times 100\\%\n$$\n$$\n\\text{Percent Suppression} = \\frac{370 \\ \\mu\\mathrm{V}}{420 \\ \\mu\\mathrm{V}} \\times 100\\% = \\frac{37}{42} \\times 100\\%\n$$\n$$\n\\frac{37}{42} \\approx 0.88095\n$$\nThus, the percent suppression is approximately $88.1\\%$.\n\n**3. Evaluation of Options**\n\n**A. L-AP4 produces an electronegative ERG by abolishing ON bipolar depolarization: the $a$-wave is largely preserved with a small decrement, the $b$-wave is strongly suppressed, and OPs are attenuated; the percent $b$-wave suppression computed from the given amplitudes is approximately $88\\%$.**\n- **Qualitative assessment**: This description matches the mechanistic predictions. \"Electronegative ERG\" is the correct term for a waveform where the $b$-wave is selectively removed, leaving a prominent $a$-wave. The statements about the $a$-wave, $b$-wave, and OPs are all correct.\n- **Quantitative assessment**: The calculated suppression of $\\approx 88\\%$ matches our derivation of $88.1\\%$.\n- **Verdict**: **Correct**.\n\n**B. L-AP4 primarily reduces photoreceptor hyperpolarization, halving the $a$-wave; the $b$-wave latency shortens and amplitude suppression is less than $10\\%$; OPs increase due to disinhibition.**\n- **Mechanistic assessment**: This is incorrect. L-AP4 acts on postsynaptic bipolar cells, not presynaptically on photoreceptors.\n- **Quantitative assessment**: The data contradicts this option. The $a$-wave is reduced by $(200-190)/200 = 5\\%$, not halved ($50\\%$). The $b$-wave suppression is $\\approx 88\\%$, not less than $10\\%$. OPs are attenuated, not increased.\n- **Verdict**: **Incorrect**.\n\n**C. L-AP4 selectively enhances OFF pathway signals, converting the scotopic $b$-wave into a large positive “$d$-wave” with a net $b$-wave amplitude increase of about $30\\%$; OPs remain unchanged.**\n- **Mechanistic assessment**: This is incorrect. L-AP4 suppresses the ON pathway. It does not enhance the OFF pathway, although blocking the ON pathway can unmask OFF responses (like the $d$-wave at light offset, not during the light flash itself in this context).\n- **Quantitative assessment**: The data shows a massive $b$-wave amplitude *decrease*, not an increase of $30\\%$. The OPs are strongly attenuated, not unchanged.\n- **Verdict**: **Incorrect**.\n\n**D. L-AP4 blocks glutamate release from rods and thus equally suppresses $a$- and $b$-waves by about $75\\%$; OPs are unaffected because they are generated distal to bipolar cells.**\n- **Mechanistic assessment**: This is fundamentally incorrect. L-AP4 is a glutamate *agonist* that acts on postsynaptic receptors; it does not block presynaptic glutamate release. OPs are generated in the inner retina, which is *downstream* or proximal to the bipolar cells, not distal.\n- **Quantitative assessment**: The data shows unequal suppression: $5\\%$ for the $a$-wave and $88\\%$ for the $b$-wave, not equal suppression of $75\\%$. OPs are affected.\n- **Verdict**: **Incorrect**.\n\nBased on the rigorous application of the provided principles and data, option A is the only one that is both qualitatively and quantitatively consistent with the expected and measured effects of L-AP4 on the scotopic ERG.", "answer": "$$\\boxed{A}$$", "id": "4721698"}, {"introduction": "In both clinical and research settings, retinal signals are invariably mixed with physiological and environmental noise. Extracting a clean, interpretable waveform from this background activity is a critical, practical challenge. This problem explores the most powerful and fundamental technique for noise reduction: signal averaging. You will derive the mathematical relationship between the number of averaged trials and the resulting improvement in signal-to-noise ratio (SNR), providing a quantitative basis for a technique used daily in every ERG laboratory [@problem_id:4721639].", "problem": "A clinician records a flash electroretinography (ERG) response from a healthy subject under photopic conditions. Each trial consists of a time-locked retinal response contaminated by Additive White Gaussian Noise (AWGN) that is independent across trials and has zero mean and constant variance at each time point. The underlying evoked signal is assumed invariant across trials. The single-trial signal-to-noise ratio (SNR), defined as the ratio of a fixed signal amplitude $A_{s}$ to the noise standard deviation $\\sigma_{n}$ measured at a specific time point of interest, is $0.5$. The clinician considers averaging $N$ trials to improve SNR and wants to compare two averaging strategies: $N=16$ and $N=64$. Starting from the definitions of averaging and the properties of independent zero-mean Gaussian noise, derive the functional dependence of the averaged-trial SNR on $N$ and compute the multiplicative change factor in SNR when moving from $N=16$ to $N=64$, defined as $\\mathrm{SNR}_{64}/\\mathrm{SNR}_{16}$. Round your final answer to four significant figures and report it as a dimensionless decimal number.", "solution": "The problem asks for two results: first, the derivation of the functional dependence of the signal-to-noise ratio (SNR) on the number of averaged trials, $N$, and second, the computation of the multiplicative change factor in SNR when increasing the number of trials from $N=16$ to $N=64$.\n\nLet us begin by formalizing the model as described in the problem statement. The recorded signal for a single trial, the $i$-th trial, at a specific time point of interest can be represented as a random variable $X_i$:\n$$X_i = A_s + n_i$$\nwhere $A_s$ is the constant, invariant amplitude of the evoked signal, and $n_i$ is the noise component for the $i$-th trial.\n\nThe problem states that the noise is Additive White Gaussian Noise (AWGN) with the following properties:\n$1$. The noise terms $n_i$ for $i=1, 2, \\dots, N$ are independent random variables.\n$2$. The noise has zero mean at each time point, so the expected value of any $n_i$ is $E[n_i] = 0$.\n$3$. The noise has a constant variance, $\\mathrm{Var}(n_i) = \\sigma_n^2$, where $\\sigma_n$ is the standard deviation of the noise for a single trial.\n\nThe single-trial Signal-to-Noise Ratio, which we denote as $\\mathrm{SNR}_1$, is defined as the ratio of the signal amplitude to the noise standard deviation.\n$$\\mathrm{SNR}_1 = \\frac{A_s}{\\sigma_n}$$\nWe are given that $\\mathrm{SNR}_1 = 0.5$.\n\nWhen $N$ trials are averaged, the resulting signal, $\\bar{X}_N$, is the arithmetic mean of the individual trials:\n$$\\bar{X}_N = \\frac{1}{N} \\sum_{i=1}^{N} X_i = \\frac{1}{N} \\sum_{i=1}^{N} (A_s + n_i)$$\nBy distributing the summation, we can separate the signal and noise components of the averaged result:\n$$\\bar{X}_N = \\left(\\frac{1}{N} \\sum_{i=1}^{N} A_s\\right) + \\left(\\frac{1}{N} \\sum_{i=1}^{N} n_i\\right)$$\nSince $A_s$ is a constant, the first term simplifies to $\\frac{1}{N}(N \\cdot A_s) = A_s$. The second term represents the averaged noise, which we can denote as $\\bar{n}_N = \\frac{1}{N} \\sum_{i=1}^{N} n_i$. Thus, the averaged signal is:\n$$\\bar{X}_N = A_s + \\bar{n}_N$$\nThe signal amplitude in the averaged trace remains $A_s$. To find the SNR of the averaged signal, we must determine the standard deviation of the averaged noise, $\\bar{n}_N$.\n\nFirst, we find the expected value of the averaged noise. By the linearity of expectation:\n$$E[\\bar{n}_N] = E\\left[\\frac{1}{N} \\sum_{i=1}^{N} n_i\\right] = \\frac{1}{N} \\sum_{i=1}^{N} E[n_i]$$\nSince $E[n_i] = 0$ for all $i$, we have:\n$$E[\\bar{n}_N] = \\frac{1}{N} \\sum_{i=1}^{N} 0 = 0$$\nThe averaged noise also has a zero mean.\n\nNext, we find the variance of the averaged noise. Using the property that $\\mathrm{Var}(cY) = c^2 \\mathrm{Var}(Y)$ for a constant $c$ and random variable $Y$:\n$$\\mathrm{Var}(\\bar{n}_N) = \\mathrm{Var}\\left(\\frac{1}{N} \\sum_{i=1}^{N} n_i\\right) = \\frac{1}{N^2} \\mathrm{Var}\\left(\\sum_{i=1}^{N} n_i\\right)$$\nBecause the noise terms $n_i$ are independent, the variance of their sum is the sum of their variances:\n$$\\mathrm{Var}\\left(\\sum_{i=1}^{N} n_i\\right) = \\sum_{i=1}^{N} \\mathrm{Var}(n_i)$$\nSince $\\mathrm{Var}(n_i) = \\sigma_n^2$ for all $i$:\n$$\\sum_{i=1}^{N} \\mathrm{Var}(n_i) = \\sum_{i=1}^{N} \\sigma_n^2 = N \\sigma_n^2$$\nSubstituting this back into the expression for the variance of the averaged noise:\n$$\\mathrm{Var}(\\bar{n}_N) = \\frac{1}{N^2} (N \\sigma_n^2) = \\frac{\\sigma_n^2}{N}$$\nThe standard deviation of the averaged noise, denoted $\\sigma_{\\bar{n}_N}$, is the square root of its variance:\n$$\\sigma_{\\bar{n}_N} = \\sqrt{\\frac{\\sigma_n^2}{N}} = \\frac{\\sigma_n}{\\sqrt{N}}$$\n\nThe SNR for the signal averaged over $N$ trials, denoted $\\mathrm{SNR}_N$, is the ratio of the signal amplitude to the standard deviation of the averaged noise:\n$$\\mathrm{SNR}_N = \\frac{A_s}{\\sigma_{\\bar{n}_N}} = \\frac{A_s}{\\sigma_n / \\sqrt{N}}$$\nRearranging this expression gives:\n$$\\mathrm{SNR}_N = \\frac{A_s}{\\sigma_n} \\sqrt{N}$$\nRecognizing that $\\mathrm{SNR}_1 = A_s / \\sigma_n$, we arrive at the functional dependence of the averaged-trial SNR on $N$:\n$$\\mathrm{SNR}_N = \\mathrm{SNR}_1 \\sqrt{N}$$\nThis result shows that the SNR improves in proportion to the square root of the number of trials averaged. This completes the first part of the problem.\n\nFor the second part, we must compute the multiplicative change factor, defined as the ratio $\\mathrm{SNR}_{64} / \\mathrm{SNR}_{16}$. Using the derived formula for $\\mathrm{SNR}_N$:\n$$\\mathrm{SNR}_{64} = \\mathrm{SNR}_1 \\sqrt{64}$$\n$$\\mathrm{SNR}_{16} = \\mathrm{SNR}_1 \\sqrt{16}$$\nThe ratio is therefore:\n$$\\frac{\\mathrm{SNR}_{64}}{\\mathrm{SNR}_{16}} = \\frac{\\mathrm{SNR}_1 \\sqrt{64}}{\\mathrm{SNR}_1 \\sqrt{16}} = \\frac{\\sqrt{64}}{\\sqrt{16}}$$\nThe single-trial SNR, $\\mathrm{SNR}_1$, cancels from the expression. Evaluating the square roots:\n$$\\frac{\\mathrm{SNR}_{64}}{\\mathrm{SNR}_{16}} = \\frac{8}{4} = 2$$\nThe multiplicative change factor in SNR when moving from $N=16$ to $N=64$ is exactly $2$. The problem requires the answer to be rounded to four significant figures, which means we express the result as $2.000$.", "answer": "$$\\boxed{2.000}$$", "id": "4721639"}]}